Ho Hao Chih, Chapital Alyssa D, Yu Mihae
Department of Surgery, Division of Surgical Critical Care, John A. Burns School of Medicine, University of Hawaii, and the Queen's Medical Center, Honolulu, Hawaii 96813, USA.
Arch Surg. 2004 Nov;139(11):1199-203. doi: 10.1001/archsurg.139.11.1199.
We hypothesized that hypothyroidism and adrenal insufficiency frequently occur together in critically ill patients.
A prospective observational study.
Surgical intensive care unit of a university-affiliated tertiary referral center.
Sixty-six consecutive patients with severe sepsis, septic shock, and hemorrhagic shock who required pulmonary artery catheterization for resuscitation were studied.
Thyrotropin and baseline cortisol levels were obtained at 3 am followed by intravenous injection of 250 mug of cosyntropin, a synthetic adrenocorticotropic hormone derivative. A second measurement of the cortisol level was performed 1 hour later.
Incidence of hypothyroidism and adrenal insufficiency and mortality.
Mean (SD) age was 62 (19) years. The mean (SD) Acute Physiology and Chronic Health Evaluation II score was 21 (5). Twenty-seven patients (40.9%) had severe sepsis, 31 (46.9%) had septic shock, and 8 (12.1%) had hemorrhagic shock. Five patients (7.6%) had hypothyroidism alone and 35 (53.0%) had only adrenal insufficiency. Eight patients (12.1%) had both hypothyroidism and adrenal insufficiency. All patients with endocrine abnormalities were treated. Mortality for the total group was 15 (22.7%) of 66 patients.
There is a 12% incidence of simultaneous hypothyroidism and adrenal insufficiency in our study and the routine testing for both may be indicated in this population of critically ill patients.
我们假设甲状腺功能减退和肾上腺功能不全在危重症患者中经常同时出现。
一项前瞻性观察性研究。
一所大学附属三级转诊中心的外科重症监护病房。
对66例因严重脓毒症、感染性休克和失血性休克而需要进行肺动脉导管插入术以进行复苏的连续患者进行了研究。
凌晨3点测定促甲状腺激素和基础皮质醇水平,随后静脉注射250微克的促肾上腺皮质激素,一种合成的促肾上腺皮质激素衍生物。1小时后再次测量皮质醇水平。
甲状腺功能减退和肾上腺功能不全的发生率及死亡率。
平均(标准差)年龄为62(19)岁。急性生理与慢性健康状况评分系统II的平均(标准差)评分为21(5)分。27例患者(40.9%)患有严重脓毒症,31例(46.9%)患有感染性休克,8例(12.1%)患有失血性休克。5例患者(7.6%)仅患有甲状腺功能减退,35例(53.0%)仅患有肾上腺功能不全。8例患者(12.1%)同时患有甲状腺功能减退和肾上腺功能不全。所有内分泌异常的患者均接受了治疗。66例患者中共有15例(22.7%)死亡。
在我们的研究中,甲状腺功能减退和肾上腺功能不全同时出现的发生率为12%,对于这类危重症患者群体,可能需要对两者进行常规检测。